Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹14 Cr₹16 Cr₹11 Cr₹11 Cr₹-0.68 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?

The latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES is ₹14 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹14 Cr
Mar2025₹16 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹-0.68 Cr

How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹14 Cr
-7.99
Mar2025 ₹16 Cr
42.73
Mar2024 ₹11 Cr
2.54
Mar2023 ₹11 Cr
Positive
Mar2022 ₹-0.68 Cr -

Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,099.2 Cr -0.2% -11.3% 204.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-0.2%

-11.3%

204.1%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses